BE-PLUS: a new base editing tool with broadened editing window and enhanced fidelity

被引:100
作者
Jiang, Wen [1 ]
Feng, Songjie [2 ,3 ,4 ]
Huang, Shisheng [2 ]
Yu, Wenxia [2 ]
Li, Guanglei [2 ]
Yang, Guang [2 ]
Liu, Yajing [2 ,3 ,4 ]
Zhang, Yu [2 ]
Zhang, Lei [3 ,4 ]
Hou, Yu [1 ]
Chen, Jia [2 ]
Chen, Jieping [1 ]
Huang, Xingxu [2 ]
机构
[1] Army Med Univ, Mil Med Univ 3, Southwest Hosp, Dept Hematol, Chongqing 400038, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 201210, Peoples R China
基金
美国国家科学基金会;
关键词
MAMMALIAN-CELLS; DEAMINASE FUSIONS; HUMAN EMBRYOS; TARGET BASE; GENOME; DNA; PROTEIN; SYSTEM; HYPERMUTATION; MUTATIONS;
D O I
10.1038/s41422-018-0052-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Base editor (BE), containing a cytidine deaminase and catalytically defective Cas9, has been widely used to perform base editing. However, the narrow editing window of BE limits its utility. Here, we developed a new editing technology named as base editor for programming larger C to U (T) scope (BE-PLUS) by fusing 10 copies of GCN4 peptide to nCas9(D10A) for recruiting scFv-APOBEC-UGI-GB1 to the target sites. The new system achieves base editing with a broadened window, resulting in an increased genome-targeting scope. Interestingly, the new system yielded much fewer unwanted indels and non-C-to-T conversions. We also demonstrated its potential use in gene disruption across the whole genome through induction of stop codons (iSTOP). Taken together, the BE-PLUS system offers a new editing tool with increased editing window and enhanced fidelity.
引用
收藏
页码:855 / 861
页数:7
相关论文
共 36 条
[1]  
ASHMAN CR, 1984, MOL CELL BIOL, V4, P2266, DOI 10.1128/MCB.4.11.2266
[2]   CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons [J].
Billon, Pierre ;
Bryant, Eric E. ;
Joseph, Sarah A. ;
Nambiar, Tarun S. ;
Hayward, Samuel B. ;
Rothstein, Rodney ;
Ciccia, Alberto .
MOLECULAR CELL, 2017, 67 (06) :1068-+
[3]   In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing [J].
Chadwick, Alexandra C. ;
Wang, Xiao ;
Musunuru, Kiran .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) :1741-+
[4]   Repair of naturally occurring mismatches can induce mutations in flanking DNA [J].
Chen, Jia ;
Miller, Brendan F. ;
Furano, Anthony V. .
ELIFE, 2014, 3
[5]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[6]   The Gam protein of bacteriophage Mu is an orthologue of eukaryotic Ku [J].
di Fagagna, FD ;
Weller, GR ;
Doherty, AJ ;
Jackson, SP .
EMBO REPORTS, 2003, 4 (01) :47-52
[7]   A NOVEL, HIGHLY STABLE FOLD OF THE IMMUNOGLOBULIN BINDING DOMAIN OF STREPTOCOCCAL PROTEIN-G [J].
GRONENBORN, AM ;
FILPULA, DR ;
ESSIG, NZ ;
ACHARI, A ;
WHITLOW, M ;
WINGFIELD, PT ;
CLORE, GM .
SCIENCE, 1991, 253 (5020) :657-661
[8]   UNIQUE PATTERN OF POINT MUTATIONS ARISING AFTER GENE-TRANSFER INTO MAMMALIAN-CELLS [J].
HAUSER, J ;
LEVINE, AS ;
DIXON, K .
EMBO JOURNAL, 1987, 6 (01) :63-67
[9]  
Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]
[10]   Development and Applications of CRISPR-Cas9 for Genome Engineering [J].
Hsu, Patrick D. ;
Lander, Eric S. ;
Zhang, Feng .
CELL, 2014, 157 (06) :1262-1278